{"brief_title": "Buprenorphine/Naloxone for Treatment of Opiate Dependence - 9", "brief_summary": "The purpose of this study is to determine the efficacy and safety of a buprenorphine/naloxone sublingual tablet formulation as an office-based therapy for opiate-dependence treatment.", "condition": "Opioid-Related Disorders", "intervention_type": "Drug", "intervention_name": "Buprenorphine/naloxone", "criteria": "Inclusion Criteria: M/F ages 21-50. Meet DSM-IV criteria for opiate dependence. Agree to conditions of the study and sign informed consent. Exclusion Criteria: Psychiatric disorder that requires medication therapy. History of seizures. Pregnant and/or nuring women. Dependence on ETOH or benzodiazepines or other sedative/hypnotics. Acute hepatitis. Other medical condtions that deem participation to be unsafe.", "gender": "All", "minimum_age": "21 Years", "maximum_age": "50 Years", "healthy_volunteers": "No", "id": "NCT00000344.xml"}